Abstract: The goal of the study was to describe the naturalistic course of unipolar major depression in subjects not receiving somatic therapy for their depressive illness. Affectively i11 individuals were recruited into the Collaborative Depression Shrdy and followed prospectively for up to i5 years. One hundled thirry subjects who recovered frorn their intake episode of major depression subsequently experrenced a recurrence that went untreated for at least 4 weeks following onset of the recurrence. The duration of the recurrent episode was examined using survival analytic techniques. Of the i30 subjects, 46 obtained somatic therapy at some time during the course of their depressive illness, while 84 subjects received no somatic therapy throughout their entire depressive episode. Survival analysis, which accounts for these 46 individuals by censoring their episodes at the time treatment was obtained, yielded a median time to recovery of 23 weeks. In the subsarnple of 84 subjects whose depressive illness went untreated from its inception tlrough its resolution, the median time to recovery was 13 weeks. These results suggest that there is a high rate ofrecovery in individuals not receiving somatic treatment of their depressive illness, particularly in the first 3 months of an episode. Because treatment-seeking behavior is known to be associated with a worse prognosis, 23 weeks probably' represents a lower-limit approximation of the median duration of an untreated depressive episode.
antidepressant therapy. Clinically, it wor-rld be especially usefo1 to know how long a depressive episode might be expected to lasr without ffeatment.
,J, Unfortunately, we have little direct knorvledge regard-{ ing the untreated course of major depression. Depression is somewhat unique among medical ailments in this regaLd, While the naturalistic, untreated course of such diseases as syphilis, tuberculosis, and gout have been described in exquisite detail for hundreds and even thousands of years, an accepted definition and standardized outcome criterion set were not established for major depressive disorder until after the introduction of effective treatment. Knowledge of the untreated conrse of depression therefore will likely require inferential analyses from studies designed for other purposes. We can identify four such tlpes of studies. First, longitudinal studies conducted prior to the introduction of antidepressant therapy could be reviewed. Second, outcomes for subjects who present for treatment but either do not receive it or are randomized to a wait-list control group could be analyzed. Third, several large scales studies have been conducted in primary care settings to evaluate the impact of improved recognition or delivery of treatment among primary care doctors. The outcomes of subjects whose depression went uffecognized or untreated over the course of follow-up (usually 6-12 months) could be ascertained. Fourtlr. the untreated course of depression could be gleaned fiom prospective, observational stLrdies conducted in the commuriry.
Each of these methods has limitations. Subjects who presented for treatment in the era prior to the infroduction of antidepressant therapy tended to be the most severely ill, and would not be representative of depressed patients toda)' (Shorter, I 997). Furtherrnore, standardized diagnostic criteria and outcome measures of depression were not available. Outcomes of subjects who enrolled in a treatment trial and were randomized to a waiting list provide perhaps the mosf valid insight we have into the naturalistic course of depres' sion, and a meta-analysis of such stltdies was conducted b]' one of the authors (Postemak and Miller, 2001) . Anothet sfudy we conclucted (Posternak and Zimmerman, 2001teval ' uated outcomes of a cohort of depressed patients who presented for treatment but who ended up not receiving antide' pressant therapy for a variety of reasons (e.g., never filled prescription, intolerable side effects). Both studies lvere lifl' ited by modest sample sizes (1/ :76 and,N : 25, respectively) and their results are, of course, generalizable only t0 ircatlnent-seeking subjects. Observational studies are limited l..l, tire nonrandom nature of their design because llontreatnent-seeking individuals tend to have a milder depressive iilness and experience less psychosocial disruption than treat11ent-seeking subjects (Coryell et al., 1995) .
Considering the widespread availabilitv of antidepresitalrt treatments and the ethical issues involved in randomizing lJcp.iessed subjects to receive no treatment. it seems unlikely ihat anv future studies will be conducted to evaluate the lutreated course of depression. Thus, despite the limitations rnherent in eacl.r of these rnethods, they provide perhaps the [ulv insight we will have into the untreated course of depresbion. Each provides a slightll' different perspective, and perhaps ns u,hole they rnay paint a reasonably accurate picture.
In the present study, we examine the course of illness in i30 subjects rvho participated in the NIMH sponsored Co[-iaborative Depression Study (CDS) and who did not receive solratic treatment following the onset of a recurrence of Lrnipolar major depression. The CDS is well sr"rited to examine this issue -qiven the standardized diagnostic and follow-up iustruments used, the size of the sample, and the length of follow-uu.
tvtETt-{oD5 0verview
From 1978 to 1981, individuals receiving inpatient or oLrtpatient treatment of a major mood disorder were recruited into the CDS at academic medical centers in Boston. Chicago, Iowa City (lorva), New York, and St. Louis. Inciusion criteria included an age of 17 years or ilrore, an IQ greater than 70. the ability to speak English, u4rite race (genetic ll",potheses tested), and no signs of a mood or psychotic disorder secondary to a general medical condition. The present stt"tdy analyzes data from the proband cohort, and does not eramine the outcomes from the cohort of relatives. After iecet'u'ing a complete description of the study, the subjects i;rot,ided written informed consent, and their subsequent '-ilttrse and treatment have since been recorded. Further deails of the study are provided elsewhere (I(eller et al., 1992) .
Subjects
A total of 955 patients entered the CDS. Within this 3x'up, 43 I were experiencing an episode of unipolar major iitpt'ession at intake into the CDS but had no underlying rrlinor depression of at least 2 years' duration. no chronic ]rlter.,ttittent depressive disorder, and no history of manla, 'ti'pomania, or schizoaffective disorder. Of these 43 I sub-.;cts.
65 had a diagnosis change to either bipolar or schizo-"ttective disorderluring the follow-up period and were ..1:ird9O from rhe anall,ies iu this anicle. bt tt. remaining jnb subjects, 318 eventually recovered frorn the intake epii 't'ce of ntajor depression during the 15-year follow-up peri,od 'ru \l€f€ at risk for a recurreltce. The other 48 subjects did j'oT recover during the follow-up period for which data are Lr arlable. ,,., O.f the 318 subjects, 130 experienced a recur:rence of -ralor depression thai rvent gntreited for at least 4 r.l,eeks "rtorving the onset of the recunence. Forly-six subjects ' -u06 Lippincou Williants & Witbins (35.4%\ ultimately obtained somatic therapy at sonre point during the course of their depressive episode. while 84 subjects did not. The median time to obtaining treatrlent in these -{6 subjects was 62 weeks. These episode durations were censored at the tine treatmerlt was obtained just as if the subjects had dropped out of the study. The rationale for including these subjects in the present study is that if we had restricted our analysis only to the 84 entirely untreated subjects, our results would have been skewed to include predominantly those untreated episodes that resolved quickly. For example, an individual who did not receive somatic therapy for their depressive illness and whose episode remitted within 8 u'eeks r.r,ould be included in the untreated cohoft, but someone who sought treatment after 2 years of unremitting depression would not. Thus, to capture these more refractory untreated cases, we chose to include those untreated individuals who eventually obtained somatic therapy.
Tabie I presents the baseline dernographic and clinical features of the entire sample (N:
130) as well as the 84 individuals who did not receive somatic tirerapy thu'oughout the entire course of the depressive episode.
Definitlon of an Llntneated Episode
Infomation regarding somatic treatrnent was collected and quantified for each week of the study using the Unipolar Cornposite Antidepressant (LNICAD) scale (Kelier, 1988) . The TNICAD employs a 5-point summary scale to rate the intensity of antidepressant somatotherapy received, including electroconr'ulsive therapy, on a weekly basis. A LTNICAD score of 0 means that no sornatic treatment was provided, and a UN'ICAD score of 4 means that treatment equal to a daily dose of 300 mg or more of imipramine or its equivalent was provided. Anxioll'tic rnedications, such as benzodiazepines, were scored on this measure with a rating of 1 to 2 depending on the n'redication and dosage (I(eller et al., 1986) . As a strictly observational study, the CDS has not influenced treatment in any way. Of note, psychotherapy rvas not coded by the IINICAD; therefore, treatment status in the present report refers only to somatic therapy.
A depressive episode was considered untreated and included in the present analysis if LNICAD ratings were 0 for at least the first 4 weeks of the depressive episode. The episode remained untreated as long as TNICAD ratings remained 0. If during any subsequent week a TNICAD rating of I or greater was obtained, the depressive episode was censored at the first such instance, as described below.
Since all probands in the CDS rvere initially recruited while in treatment, the intake episode, by definition, was excluded from our analysis. Following recovery from the index episode, treatment ratings were exarnined in subjects who experienced one or more recurences. The first episode of major depression that went untreated by our critcria n,as included in our analyses. For subjects who had rnore than one untreated episode (1/: 35, I i9lo). oniy the first such episode was included. In the present repofi, when recovery occured without standar-d antidepressant somatic therapy. rve use the term spontaneotts renissiorz to denote that process. variables, including the severity of psychopathology on 3 weekly basis, and the type and dose of all prescribed psych, otropic medications. The severity of psychopathology 15 quantified on a 6-point scale called the Psychiatric Status Rating (PSR), which can be assigned to any major affective disorder. and which has been shown to have good to excellent interater and test-retest reliability (I(eller et al., 1987; Warshaw et a1., 7994) . At each interview, the rater assigns a PSR for each week of the study, stafting from the last inter-view, To accomplish this, the rater first reviews the subject's status at the time of the preceding interv'iew, and then identifles chronoiogical anchor points, such as holidays to help the subject remember when significant clinical improrrement or deterioration occurred. Patient recall of psychopathology using autobiographical markers of memory (Shun, 1988) has been shown be both reliable and valid (Warshaw et al., 1994; Zimmeman and Coiyell, 1986) . In addition, corroborative data are obtained from medical records and informants.
A PSR of I or 2 is assigned for those weeks in which there are no or minimal symptoms, respectively. A PSR of 3 or 4 corresponds to parlial remission or significant symptoms not meeting full criteria for an RDC major affective disorder, respectively. A PSR of 5 is given for those weeks during which subjects meet fuil criteria for an RDC major affective disorder, and a 6 when accompanied by psychosis or extrene impairment. Recovery from major depression is defined by RDC as beginning with the first of 8 consecutive weeks of no or minimal symptoms (PSR of I or 2). Recurrence was defined as the reappearance of RDC major depressive disorder meeting the full criteria for at least 2 consecutive weeks. beginning with the first of these 2 weeks. Recurrence occurred only after the individual had first recovered from his or her preceding mood episode. Episodes of RDC minor depression and chronic intermittent denression were not included in these analyses.
Statistical Analyses
Duration of episodes rvere examined using survival analytic techniques (Kalbleish and Prentice, 1980) . These analyses account for varying lengths of follow-up and estimate the changing probability of recovery at different tirnes I over the course of follow-up. The survival time (duration of r episode) began at the onset of the major depressive episode. The event that ended each episode was the period of at leasti 8 consecutive weeks of recovery. The week prior to this 8-week period constituted the final week of the depressilel episode. A censored case is one in whom remission was notl observed during an untreated interual. Specifically, a casel was classified as censored if the subject follow-up ended priorl to remission or that subject remained depressed and untreaterl at the end of the l5-year follow-up period. For the 4b] tuntreated subjects who eventually received somatic therapv.] the episode was censored at the time treatment was obtaineci In this i,vay, the tecl.rniques minimize the effects of censorecl data by including all subjects who began the obser-vatiorperiod re-eardless of whether they finished it. The cr,rmulativrl probability of spontaneous remission was estimated with th.1 I(ap1an-Meier product lirnit (Kaplan and Vleier, 1958 
Assessments
Current and past psychiatric histories rvere assessed at baseline using the Schedule for Affective Disorders and Schizophrenia . Diagnoses were made according to the Research Diagnostic Criteria (RDC; Spitzer et al., 1978) , following interviews with probands, and at times, relatives, as well as a revier.v of available rnedical records.
Follow-up assessments were cornpleted every 6 months for the first 5 yeals of the study and annually thereafter r-rsing the Longitudinal Inten,al Follow-up Evaluation (Keller et al., 1987) . The Longitr-rdinal Interval Follow-Lrp Evaluation is a sernistnrctr.u'ed instmment that measules nulnerous clinical 326 e 2(,)06 Lippincott It'illinms & Ll-ilkitt T h e I o u r n a I !!!:!9 u: ! tl ! tv! 3 tl t olpf grygj tr9! rq Number 5, r.epresent the proportioti of those entering a discrete follotv-up inierr,al in a major depressive episode who recovered during rhe interval'
To exaurine predictors of recovery, u,e evaluated seven demographic and clinical features: age (under 30, 30-39, l0' 19, and 50 and older) . sex, number of lifetime depressive eprsodes, age of onset of depression, social class. cornorbid iinxiety disorder, and comorbid substance use disorder. These sevell pararneters were placed in a cox regression model, ru,hich accounts for independent contributions fi'orn each r ariable. Figure I depicts the course ofthe 130 subjects inclusive olthe 46 depressed subjects who initially went untreated but later sought antidepressant treatment prior to recovery. The median time to recovery in this sample was 23 weeks. The curnulative monthly recovery rates were 750/o after 1 montir, 26% after 2 months, 38oh af\er 3 months, 52o/o after 6 months, 7090 after i year, and 75o/o after 2 years. Figure I also depicts the time to recovery in the 84 subjects whose depressive illness went untreated from inception through resolution. The median time to recovery in this cohoft was 13 weeks. The cumulative rnonthly recovery rates lere 23o/o after I month.37o/o after 2 months. 52o/o after 3 nronths, 610/o after 6 months, and 85ok and 89o/o after I and 2 lears, respectively. Spontaneous remission was most likely to occur in the first 3 months following onset: in the first 3 ntonths, 52n,'o of the subjects recovered, whereas only l5o/o, li9'i, and 10-9.'o recovered in the three subsequent 3-month periods.
RESULTS
. In examining predictors of recovery, we found that age lp = 14.7, df : 3, p : 0.002) but not sex, number of prior episodes, age of onset, social class, or comorbid anxiety or substance use disorders were sienificantlv associated with The Naturolistic Course of Unipolor Maior spontaneous recovery. Specifically, compared with the 30to 39 cohort, subjects under age 30 wele twice as likely to recover (OR : 2.0, Cl: 1. l-3.9). and subjects aged 40 to 49 were five times more likely to recovel (OR : 5.3, CI : 2.1-13.8). It is unclear wl.rether this unexpected filding represents a spulious finding 01' a tlue distinction in recovery rates.
D!SCUS5!ON
While the waxing and waning course of major depression has long been recognized, surprisingly little attention has been paid to the occunence of spontaneous remission. I(raepelin speculated that left rurtreated, major depressive episodes would tend to last about 6 to 8 months in rnost cases (Ikaepelin, 1921) . Subsequent reports have generally supported this assertion (Angst, 1986; Hohman, 7937 Huston and Locher, 1948; Rennie and Fowler, 1942; Shobe and Brion, 1971) , though these sfudies were largely based on clinical obserr,,ation and retrospective analyses. The present study provides perhaps the most methodologically rigorous confirmation of this estirnate.
The major limitation of the present study is that subjects were not randomized to receive no treatment. Depressed individuals who do not receive somatic treatment have been shown to experience less economic disruption as a result of their illness compared with treatment-seeking patients (Coryeil et al., 1995) . In assessing tirne to recovery in a cohort ofsubjects ftom the CDS that included both subjects who had and had not received somatic treatment of their depressive illness, Keller et al. (1992) reporled recovery rates of 19% within 4 weeks, 31%o within 8 weeks,41% within 13 weeks, 54ohwtthin 26 weeks, and 70oh within 1 year. Since subjects who did not receive somatic therapy from the present analysis recovered more quicldy fiom their depressive episode, this suggests that nontreatment-seeking individuals have an inherently better prognosis than treatment-seeking individuals. Thus, our results cannot necessadly be generalized to the treahnent-seeking population.
For this reason, we would posit that 23 weeks is a lower limit approximation of the median duration of major depression in the absence of somatic theraov. Because we have insufficient data regarding the course of untreated major depression in the treatment-seeking population, and because chronicity is likely to be overrepresented in this cohort, we do not know whether the natural duration ofrnajor depression is significantly longer than 23 weeks.
Our analysis ofthe subgroup ofdepressed subjects who went without somatic therapy throughout the entire course of their depressive illness yielded a median episode duration of 13 weeks-nearly identical to what Coryell et al. (1995) reported in a separate cohort of subjects who did not receive somatic treatment. Subseqr.tent to the first 3 months of illness, the spontaneous remission rate appears to decrease dramatically, though a substantial number continue to recover so that by the end of I year, only 15o/o of the subjects who had not received any antidepressant medication treatment were still depressed.
Such a high spontaneous remission rate lnay explain why studies conducted in primary cale settings airned at increasing the detection of major depression (Coyne et al., 0.8 '- ll h e n,r 1997; Omrel et a1., 1991; Schulberg et a1., 1987; Simon et al., 1999; Tiemens et al., 1996 Tiemens et al., , 1999 . or using more aggressive treatment (l(oenig et al., l9B9; Magmder-Habib et ai., 1989; Schuiberg et a1., 1991; Simon et a1., i995) . have often failed to demonstrate improved outconres compared with usual care. If as many as 85% of depressed individuals who go without somatic treatment spontaneously recover within 1 year, it would be extrernely difficult for any intervention to demonstrate a superior result to this. We would recommend, as has been suggested elsewhere (Coryell et al., 1994) , that such studies consider including only patients who have been depressed for a minimr.rm of 3 months. since it is during this time that spontaneous remission is most likely to occur. Our results also allorv us to estimate the percentage of subjects enrolled in controlled treatment trials who experience a spontaneous remission of synptorns. If 50% of depressed individuals spontaneously recover within 6 months, then the spontaneous remission rate of depression would be aborfi2oh per week during this time frame. An estimate of the naturalistic conrse of depression in treatment-seeking individuals was pllt forth in a recent meta-analysis that evaluated the outcomes of depressed subjects who were randomized to a no-treatment control group (Postemak and Miller, 2001) . The authors reported that l5 of 76 (19.7%) subjects who were randomized to a wait-list control group experienced a spontaneous remission of symptoms over an average of 10 weeks-which again translates into a2o/o weekly spontaneous remission rate. If this figure is accurate, then 129/o to l6ok of subjects enrolled in standard antidepressant efficacy trials might be expected to experience spontaneous remission during the course of a treatment trial of 6 to 8 weeks-irrespective of whether they are randomized to active medication or placebo. Because remission of symptoms signifies greater improvement than response (usually defined as a >50o/o reduction in symptom severity), the percentage of spontaneous responders may even be higher. Thus, spontaneous improvement may account for a significant proportion of the 30% to 35% placebo response rate that is typically reported in antidepressant trials, as has similarly been suggested elsewhere (Hrobjartsson and Gotzshce. 2001) .
Several limitations to the present study should be kept in mind. First, subjects were not landornized to receive or not receive somatic therapy, and our results can not be -eeneralized to the treatment-seeking population. Second, psychotherapy was not accounted lor in our assessment of treatment status, and it is likely that solne subjects who ',ve have labeled as untreated were actually receiving psychotherapy. Two recent str-rdies, however, suggest that only a small percentage (around 10%) of depressed patients treated in the community receive psychothelapy alone (i.e.. without sonlatic therapy; Greenfield et al., 2000; Parker et al.. 2001) . A third iimitation is that subjects in the present study were recruited fi'om psychiatric settings and not through prirnary care doctors. Thus, any extrapolation of our results to the prinrary care setting shor"rld be done cautiously. especially since depressed patienis with medical comolbidity rray have a worse prognosis (Keitner et a1., l99l t. Fourth. all suhjects v,'ere initially
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The lournol of Nervous ond Mental Diseose . Volume 194, Number 5, (ll recruited from academic centers, and such patients ma] differ from those treated in the community. Fifth, because our aoat rvas to examine prospectively the course of major depresijon in the absence of somatic therapy, onr analyses focused on the first depressive recunence that went untreated arrd e\. cluded the intake episode. Thus, or.rr results may not gener. alize to first episodes. Furthermore, 48 of 366 subjects nevsl recovered from their intake episode, and this refractory c0. hort could not be accounted for in our analyses.
Finally, it should also be pointed out that the present sfudy did not examine the risk for recurrence, which may ls as high as 5096 in the first year following recovery (Coryell et al.,1991; Faravelli et a1., 1986; I(eller et al., 1983; Ramana et a1., 1995) . Becarise antidepressant treatment has been shown to reduce the risk of recurrence (Maj et a1., 1992 : Vigr-rera et al., 1997 , it is possible that patients whose depres. sive illness spontaneously remits might still benefit fiom such [€atment as prophyiaxis against future recurrences. 
